Rober Habashy MSc

Mr. Rober Habashy leads SGS Quay Pharma’s Pre-Clinical Group, overseeing development activities including solid-state characterization and analytical method development services, as well as leading the development and supply of formulations for preclinical evaluation.

Mr. Habashy has held several roles in multinational organizations covering concepts of commercialization. He earned a Master of Science degree in Industrial Pharmaceutics at the University of Central Lancashire where he also worked as a Senior Researcher specializing in and publishing research on novel natural coating technologies and 3D printing approaches for product development.